Health Canada is informing Canadians that GlaxoSmithKline (GSK) has begun to voluntarily recall, LOT# 5R6 of their product, Emo-Cort 2.5% Lotion currently available on the Canadian market. GSK is requesting that wholesalers, pharmacies and hospitals immediately stop sale of this lot. Emo-Cort (hydrocortisone) 2.5% Lotion is used in the treatment of eczema, dermatitis and other skin irritations.
This recall comes as a result of a consumer complaint to
GSK regarding a brown substance in the product. As a result of
GSK's testing of several LOT# 5R6 samples, the presence of mould contamination has been identified. There is a potential risk of local or more widespread infection from the mould contamination in those Canadians with weakened immune systems. In light of this information,
GSK, as a precautionary measure, is putting all its Emo-Cort products at the manufacturing facility on hold pending their investigation.
Canadians may wish to consult with their healthcare practitioner if they have used this product or about the appropriateness of alternatives currently authorized and available on the Canadian market.
GSK had recently recalled a similar product, Emo-Cort 1%, lot# 12R7, from the Canadian market due to mould contamination. For more information on this
recall, please visit Health Canada's web site.
Health Canada will continue monitoring the safety of all health products on the Canadian market, including those sold by
GSK and will inform Canadians and take appropriate action if new safety information arises.
Health Canada reminds Canadians who have concerns about these products that they may wish to also contact
GSK at 1-800-387-7374.
To report suspected adverse reaction to these or other health products, please contact Health Canada's Canada Vigilance Program toll-free at 1-866-234-2345, or complete a
Canada Vigilance Reporting Form and send to us using one of these methods:
Health Canada
613-957-2983
613-957-2991
1-866-225-0709